Cognitive and motor development in infants at risk for human immunodeficiency virus
E. H. Aylward, A. M. Butz, N. Hutton, M. L. Joyner and J. W. Vogelhut
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University Medical Institutions, Baltimore, Md.
To evaluate the natural course of cognitive and motor development among
infants infected with human immunodeficiency virus from birth, the Bayley
Scales of Infant Development were administered to 96 infants between 5.5
and 24 months of age. Infants were divided into three groups on the basis
of subsequent assessment of human immunodeficiency virus serologic status:
seronegative (N = 45), seropositive (N = 12), and seroreverter (N = 39).
Groups did not differ in race, infant age at initial testing, maternal age,
maternal education level, maternal history of intravenous drug abuse, or
percentage of children in foster care placement. Significant group
differences were found on the Mental Development Index and Psychomotor
Development Index, with the seropositive infants scoring significantly
lower than the seronegative or seroreverter infants.
A Behavioral and Cognitive Profile of Clinically Stable HIV-Infected Children
Nozyce et al.
Pediatrics 2006;117:763-770.
ABSTRACT
| FULL TEXT
Neurocognitive Functioning in Pediatric Human Immunodeficiency Virus Infection: Effects of Combined Therapy
Shanbhag et al.
Arch Pediatr Adolesc Med 2005;159:651-656.
ABSTRACT
| FULL TEXT
Neuropsychological Functioning and Viral Load in Stable Antiretroviral Therapy-Experienced HIV-Infected Children
Jeremy et al.
Pediatrics 2005;115:380-387.
ABSTRACT
| FULL TEXT
Babies of a pandemic
Stein et al.
Arch. Dis. Child. 2005;90:116-118.
FULL TEXT
Predicting HIV Disease Progression in Children Using Measures of Neuropsychological and Neurological Functioning
Pearson et al.
Pediatrics 2000;106:76e-76.
ABSTRACT
| FULL TEXT
Early Language Development in Children Exposed to or Infected With Human Immunodeficiency Virus
Coplan et al.
Pediatrics 1998;102:8e-8.
ABSTRACT
| FULL TEXT
Neurodevelopmental Outcomes of Ugandan Infants With Human Immunodeficiency Virus Type 1 Infection
Drotar et al.
Pediatrics 1997;100:e5-e5.
ABSTRACT
| FULL TEXT
Neurodevelopment in Pediatric HIV Infection: The Use of CAT/CLAMS
Wachtel et al.
CLIN PEDIATR 1994;33:416-420.
ABSTRACT